Matches in Wikidata for { <http://www.wikidata.org/entity/Q77921953> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q77921953 description "artículu científicu espublizáu en payares de 1998" @default.
- Q77921953 description "im November 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q77921953 description "scientific article published on 01 November 1998" @default.
- Q77921953 description "wetenschappelijk artikel" @default.
- Q77921953 description "наукова стаття, опублікована в листопаді 1998" @default.
- Q77921953 name "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 name "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 type Item @default.
- Q77921953 label "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 label "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 prefLabel "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 prefLabel "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 P1433 Q77921953-0D4BDA5A-3041-4EC7-B26A-A041ABF511EB @default.
- Q77921953 P1476 Q77921953-3C5BD7FB-4770-49EE-A34E-9147E20E3B34 @default.
- Q77921953 P2093 Q77921953-58BF258E-5ED8-40D6-9F0B-A21FFB17BAD3 @default.
- Q77921953 P2093 Q77921953-C6E23336-2EBE-433B-B6D8-333CC8A2D600 @default.
- Q77921953 P2093 Q77921953-CF404A4C-BBA5-44AF-8910-B7916E11845F @default.
- Q77921953 P2093 Q77921953-E5B90496-D73B-4466-8E89-EF3DDE7F87D0 @default.
- Q77921953 P2093 Q77921953-E9EB33E0-E9C1-41F2-A0FB-E29C17FB9637 @default.
- Q77921953 P2888 Q77921953-B0B4A193-37AA-4AE9-83A4-CAD951228956 @default.
- Q77921953 P304 Q77921953-0564D566-8ED3-4F0A-81AB-5574C00B5E20 @default.
- Q77921953 P31 Q77921953-3D269A47-3E1C-4057-8E54-FC340FD56127 @default.
- Q77921953 P356 Q77921953-586594E8-D700-4E97-8B89-E8745B6AB518 @default.
- Q77921953 P433 Q77921953-FD3F02FD-D88B-42A5-AA8F-FFDBB8FB4FF5 @default.
- Q77921953 P478 Q77921953-790965D3-A88C-492E-BEBD-63DEE0748805 @default.
- Q77921953 P50 Q77921953-03C76514-C803-4455-A62E-5216C212C911 @default.
- Q77921953 P577 Q77921953-71157F02-9DFD-4AE2-A988-93E3B75D9822 @default.
- Q77921953 P698 Q77921953-DB8AEE75-CCE7-4A08-93B3-05284AAFF4B4 @default.
- Q77921953 P921 Q77921953-BEFF4ACD-7280-415A-828D-C63A954F71BC @default.
- Q77921953 P356 S002280050537 @default.
- Q77921953 P698 9923570 @default.
- Q77921953 P1433 Q1376707 @default.
- Q77921953 P1476 "Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage" @default.
- Q77921953 P2093 "A Nagyová" @default.
- Q77921953 P2093 "K Raslová" @default.
- Q77921953 P2093 "M Dobiásová" @default.
- Q77921953 P2093 "M Dusinská" @default.
- Q77921953 P2093 "R Fábry" @default.
- Q77921953 P2888 s002280050537 @default.
- Q77921953 P304 "697-699" @default.
- Q77921953 P31 Q13442814 @default.
- Q77921953 P356 "10.1007/S002280050537" @default.
- Q77921953 P433 "9-10" @default.
- Q77921953 P478 "54" @default.
- Q77921953 P50 Q89798220 @default.
- Q77921953 P577 "1998-11-01T00:00:00Z" @default.
- Q77921953 P698 "9923570" @default.
- Q77921953 P921 Q104053 @default.